You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Improved Ultrafilters for Bioprocessing
SBC: Abel Company Topic: N/AEfficient separation and purification of bioproducts on a commercial scale are controlling steps in the bioprocessing of high value-added products such as therapeutics in human health care. This project will examine the feasibility of achieving significant improvement in downstream processing through-put by the use of flow-induced vortices to reduce or eliminate the effect of concentration polariz ...
SBIR Phase I 1993 Department of Health and Human Services -
HEART RATE VARIABILITY ANALYSIS USING POLYNOMIAL NETWORK
SBC: ABTECH CORPORATION Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
LONG RANGE POPULATION PROJECTION BY DISABILITY STATUS
SBC: Actuarial Research Corporation Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
LONG-TERM CARE INSURANCE: A MANUAL FOR REGULATORS
SBC: Actuarial Research Corporation Topic: N/AN/A
SBIR Phase I 1990 Department of Health and Human Services -
PSO ACTUARIAL RATE MODEL FOR MEDICARE RISK CONTRACTS
SBC: Actuarial Research Corporation Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
Long Acting Agonists of Adenosine A2a Receptors
SBC: ADENOSINE THERAPEUTICS, LLC Topic: N/ADESCRIPTION (provided by applicant): Adenosine is an endogenous nucleoside that exerts its physiological effects through four G-protein coupled receptors A1, A2A, A2B, and A3. Adenosine Therapeutics, LLC is interested in the anti-inflammatory actions mediated by the A2A receptor subtype. A lead compound, ATL-146e, is being developed for coronary artery imaging and has also been shown to be effi ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
Icon-Based Courseware for Alcoholism Assessment Training
SBC: American Research Corporation of Virginia Topic: N/ANIAAA has identified the need for education materials which facilitate the training of health professionals and paraprofessionals in the use of various alcoholism assessment techniques and instruments. In response to this need, we will develop a icon-based courseware for alcoholism appraisal training and instruction. Specific aims of the research include selection of alcoholism assessment methodol ...
SBIR Phase I 1993 Department of Health and Human Services -
Portable Computer¿Based Interrogator for Sleep Disorder
SBC: American Research Corporation of Virginia Topic: N/AThe objective of this contract is to develop monitoring technology to accurately screen patients on an outpatient basis by monitoring physiologic variables capable of indicating whether or not there is a need for future, more costly, sleep disorder testing. The Contractor shall perform the following 1) an evaluation of data presentation requirements to establish the basis for a multiple test batte ...
SBIR Phase I 1993 Department of Health and Human Services -
Interactive Computer Graphics for Teenage Sex Education
SBC: American Research Corporation of Virginia Topic: N/AThe National Institute of Child Health and Human Development has identified the need for programs to delay the onset of sexual activity among adolescents and to increase contraceptive protection of the adolescents who are sexually active. In response to this need, we will develop a hypermedia-based intelligent interface for teenager sexuality education. Specific aims include development of instruc ...
SBIR Phase I 1993 Department of Health and Human Services -
Aptamer Array Finds Metabolic Change from Hepatotoxicity
SBC: American Research Corporation of Virginia Topic: N/ADESCRIPTION (provided by applicant): In order to reduce the costs of drug development and improve methods of detecting environmental effects of xeniobiotics, there is a need for in vitro methods of xeniobiotics identifying toxicity of materials to specific organs that do not require a whole-animal model. In particular, methods capable of identifying hepatotoxicity either require extensive animal ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health